Nvidia Corporation's stock dip offers a buying opportunity, with 78% revenue growth and market dominance in AI GPUs. Click ...

TG Therapeutics (TGTX) stock spikes as Roche (RHHBY) fails in a Phase 3 trial for a high dose version of its multiple ...

Delcath's Q4 sales exceeded expectations due to HEPZATO KIT adoption. Discover insights into its profitability, CHOPIN trial ...

Advanced Micro Devices, Inc. faces challenges in the slowing AI market, with Nvidia's dominance and custom chips reshaping ...

CoreWeave’s 2022 to 2024 financial path is one of hypergrowth, efficiency improvement, and early-stage profitability. In 2022 ...

BB Seguridade Participações S.A. offers a 9% dividend yield but is overvalued. Click for my look at BBSEY stock and its big ...

Exxon Mobil's stock remains steady year-over-year. Learn why the recent price rise may not last and explore its long-term ...

Will tariffs cause inflation and higher interest rates? Jitania Kandhari discusses how subsidies, sanctions & security ...

Overall, the fourth quarter of 2024 was characterized by resilient labor market dynamics, strong economic growth and sticky ...

Newsmax Inc.'s 17x surge defies fundamentals and faces profitability challenges. Here's why experts urge caution on highly ...

This month’s Protean Funds Scandinavia AB letter elaborates on why we are starting a low-cost active fund and provides color ...

President Trump's tariffs aim to cut a $1.20T trade deficit but may risk market instability & economic slowdown. Click for ...